Results 101 to 110 of about 92,115 (273)

The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function

open access: yesAsian Journal of Surgery, 2019
Summary: Background: It is unclear whether neoadjuvant chemoradiation for lower rectal cancer causes a deterioration in urinary function. This study aimed to prospectively compare the postoperative urinary function of patients with lower rectal cancer ...
Yugo Hirata   +9 more
doaj   +1 more source

Neoadjuvant Chemoradiotherapy and Postoperative Digestive Fistula

open access: yesJOURNAL OF SURGICAL AND CLINICAL RESEARCH
The pivotal role of neoadjuvant chemotherapy and radiotherapy in enhancing the management of gastrointestinal cancers is incontrovertible. However, their implications for surgical outcomes, particularly the risk of postoperative anastomotic fistulas, necessitate comprehensive analysis. This review examines the intricate relationship between neoadjuvant
Irami Araujo-Filho   +1 more
openaire   +1 more source

Heterogeneity Analyzed by CT‐Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tumors are highly heterogeneous, and whole‐lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction.
Yang Zhang   +2 more
wiley   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy

open access: yesTrials
Background The Preoperative Immunonutrition Therapy (POINT) trial compares immunonutrition supplements with a regular diet for surgically resectable esophageal patients during neoadjuvant chemoradiotherapy.
Yumeng Cheng   +18 more
doaj   +1 more source

Spatially Aware Acquisition‐Independent Deep Learning for IVIM MRI Parameter Estimation in Patients With Esophageal Cancer

open access: yesMagnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose Neural controlled differential equations (NCDEs) recently emerged as a robust deep learning approach for quantitative MRI parameter estimation. NCDEs offer flexibility to changes in acquisition protocols by modeling the signal evolution dynamics. However, NCDE implementations operate on a voxel‐by‐voxel basis and cannot exploit spatial
Daan Kuppens   +5 more
wiley   +1 more source

Stenosis and distortion of reconstructed rectum after neoadjuvant chemoradiotherapy and anterior resection procedure for patients with local advanced mid-low rectal cancer: risk factors and clinical management

open access: yesZhongguo aizheng zazhi, 2018
Background and purpose: Neoadjuvant chemoradiotherapy has become standard treatment modality for locally advanced mid-low rectal cancer. This study aimed to analyze the risk factors of stenosis and distortion in reconstructed rectum after neoadjuvant ...
郑宏途, 杨立峰
doaj  

Neoadjuvant Therapy in Locally Advanced Rectal Cancer—What Result Should We Expect?

open access: yesMedicina
Background and Objectives: Neoadjuvant chemoradiotherapy is a key component of the treatment strategy for locally advanced rectal cancer (LARC), both through its direct impact on oncological prognosis and by increasing the likelihood of sphincter ...
Roxana-Elena Stefan   +11 more
doaj   +1 more source

Precise delineation of radiation targets for thoracic tumors in the immunotherapy era: from immune mechanisms to clinical practice

open access: yesPrecision Radiation Oncology, EarlyView.
RT‐immunotherapy synergy for thoracic tumors relies on precise target delineation to protect immune components. IFI, reduced volumes, and optimized positioning minimize damage, while multimodal imaging, DL, PBT, and FLASH‐RT enhance control. These innovations shift RT to an immune‐centric model, improving lung and esophageal cancer outcomes.
Xiaoying Chen   +3 more
wiley   +1 more source

Esophageal Cancer : Neoadjuvant chemoradiotherapy and surgery [PDF]

open access: yes, 2018
This thesis consists of two parts. In part I the implications of neoadjuvant chemoradiotherapy on surgical treatment of esophageal cancer are described.
Noordman, B.J. (Bo Jan)
core   +3 more sources

Home - About - Disclaimer - Privacy